Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including dermatology and immunology therapies, is expected to support Arcutis' growth and pipeline expansion, particularly for its ZORYVE product line. His leadership background includes roles at AbbVie, Amgen, and Pfizer, where he contributed to major drug approvals. This strategic move aims to enhance Arcutis' efforts in delivering new treatments for chronic inflammatory skin diseases.
Arcutis Biotherapeutics' board appointment news comes as the health sector on Pluang showed a broad decline, with 95 of 150 priced US health stocks falling as of Oct 28, 2026, 19:43 WIB. For readers following health stocks, Tilray Brands Inc (TLRY) traded at USD 2.72 with a 1-day change of -1.81%, Immunovant Inc. (IMVT) rose by 1.80% to USD 29.40, and Moderna, Inc. (MRNA) was priced at USD 204.55, down 1.64%, with Pluang order activity heavily skewed to 80% sell and 20% buy.
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
Circuit Mind secured $25 million in funding, including an $18.5 million Series A led by Norwest, to expand its AI platform that automates and optimizes electronic circuit board design. The platform helps companies reduce design time by up to 90%, cut...
